Plasma concentrations of B-type natriuretic peptide (BNP) were analysed during the peri-and post-operative periods in cardiac surgery patients, and the relationship between plasma BNP concentrations and various clinical parameters was explored. Thirty patients (17 women, 13 men) of age 54.5 ± 17.1 years undergoing cardiac surgery between June 2004 and March 2005 were enrolled. Plasma BNP concentrations were measured pre-operatively, immediately post-operatively, and on the first, second, fourth and seventh post-operative days.
Introduction
One of the major challenges during cardiac surgery is to protect the heart from ischaemic and reperfusion injury. The B-type natriuretic peptide (BNP), also known as brain natriuretic peptide, is thought to be a counter-regulatory hormone that helps preserve the heart. 1 Endogenous BNP was first discovered in pig brains in 1988. 2 It is released by cardiomyocytes following ventricular distension, as seen during volume overload in heart failure. BNP exerts several effects that protect the heart from injury: it is a potent vasodilator and reduces pulmonary artery pressure, leading to reduced pulmonary and systolic vascular resistance, it increases the glomerular filtration rate and stimulates urine output, and it decreases myocardial oxygen consumption through an unknown DS Jeong, K-H Kim, CY Kim et al. B-type natriuretic peptide and ventricular function mechanism, while increasing coronary blood flow. 3 -5 B-type natriuretic peptide is emerging as an important independent indicator of left ventricular function and may have an additional prognostic role following myocardial infarction and in congestive heart failure. Its stability in vitro has been verified by several studies, making it a potentially valuable and practical biochemical marker of underlying cardiac function. 6 Measuring the plasma concentrations of BNP and the inactive amino-terminal fragment of the precursor of BNP (N-terminal proBNP) in heart failure provides prognostic information and can guide the choice of pharmacotherapy. Some studies have shown that the BNP concentration can act as a non-invasive monitor of disease progression and as an early marker of left ventricular dysfunction; all these studies report higher BNP concentrations with increasing severity of symptoms. 7 -9 While many reports have examined plasma BNP concentrations in chronic heart failure, few have explored BNP levels in acute heart failure. In addition, the effect of cardiac surgery on plasma BNP concentrations has not yet been clarified. The purpose of the present study was to analyse levels of BNP during the peri-and post-operative periods in patients undergoing cardiac surgery, and to explore the relationship between plasma BNP concentration and various clinical parameters.
Patients and methods

PATIENTS
Patients undergoing cardiac surgery performed by a single surgeon in Seoul National University Hospital between June 2004 and March 2005 were enrolled in this study. In this study, the patients enrolled were consecutive cardiac surgery patients. Only those patients who rejected the suggestion of our study were excluded. The study protocol was reviewed by the Institutional Review Board and approved as a minimal risk retrospective study (approval no. R-0603-013-169) that did not require individual consent based on the institute's guidelines for waiving consent.
OPERATIVE CONDITIONS
Intra-operative anaesthetic management was the same for all patients and all operations were performed through a median sternotomy. The superior and inferior vena cavae and ascending aorta were cannulated separately for cardiopulmonary bypass. Heparin at a dose of 2.5 mg/kg body weight was administered to maintain an activated clotting time of > 400 s during cardiopulmonary bypass. In addition to moderate systemic hypothermia, a cold crystalloid cardioplegic solution was administered continuously via the aortic root or coronary sinus. Oxygenation was performed by a membrane oxygenator. Following termination of the cardiopulmonary bypass, protamine sulphate was administered at a ratio of 1:1 to the total heparin dose to neutralize its effects.
MEASUREMENT OF BNP
Blood samples for the measurement of plasma BNP concentrations were drawn from peripheral arteries or veins into ethylenediaminetetraacetic acid sodium (EDTA) tubes pre-operatively, immediately post-operatively, and on the first, second, fourth and seventh post-operative days. The BNP was measured using a fluorescence immunoassay kit (Triage ® , Biosite Diagnostics Inc., San Diego, CA, USA). The precision, analytic sensitivity and stability
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characteristics of this method have been published previously. 10 
STATISTICAL ANALYSIS
Results were expressed as the mean ± SD. Comparisons of plasma BNP concentrations at different times were evaluated using repeated measures analysis of variance (ANOVA). Correlations between BNP concentrations and clinical data were assessed using linear regression analysis. A P-value < 0.05 was considered to be statistically significant.
Results
Thirty patients were enrolled in the study. The most common pre-operative diagnosis was valvular heart disease ( Table 1 ). The patients' pre-operative clinical characteristics are summarized in Table 2 .
Surgery performed included valve replacements, valve repairs, aortic replacement and coronary artery bypass grafts ( Table 3 ). The mean ± SD total cardiopulmonary bypass (CPB) time was 213.3 ± 58.8 min (range 125 -339 min) and the mean ± SD aortic cross clamp (ACC) time was 134.4 ± 44.2 min (range 70 -228 min).
The left ventricular ejection fraction, left ventricular end-diastolic dimension, left ventricular end-systolic dimension and pulmonary artery pressure were not significantly different after cardiac surgery compared with prior to surgery (data not shown). There was no mortality. Preoperative severe left ventricular dysfunction in nine patients affected post-operative recovery. Except for post-operative left ventricular dysfunction, there were no complications such as new onset atrial fibrillation, mediastinitis, renal failure or post-operative bleeding. 
PRE-OPERATIVE PLASMA BNP CONCENTRATIONS
The mean ± SD pre-operative plasma BNP concentration, defined as the baseline, was 384.6 ± 963.5 pg/ml (range 5.0 -5000 pg/ml). Pre-operative BNP levels correlated significantly with left ventricular ejection fraction and age (P = 0.002 and 0.031, respectively); there were no other significant correlations with pre-operative clinical data ( Table 4 and Fig. 1 ). Six patients showed pre-operative plasma BNP concentrations > 500 pg/ml; the profiles of this group are listed in Table  5 . In this group the mean ± SD for CPB time was 263 ± 47.1 min and the mean ± SD for ACC time was 178 ± 38.8 min. Most of these patients had congestive heart failure pre-operatively and all but one underwent two or more cardiac procedures. Patients 5 and 6 ( 
TABLE 4: Correlations (r) between B-type natriuretic peptide (BNP) levels and various pre-operative clinical variables
POST-OPERATIVE PLASMA BNP CONCENTRATIONS
The BNP level was not significantly increased immediately post-operatively, but was significantly increased by the first post-operative day (P = 0.027). BNP concentrations then returned to near baseline values by the seventh postoperative day ( Table 6 and Fig. 2) . Of the six patients with a pre-operative plasma BNP concentration > 500 pg/ml, BNP levels had fallen by the seventh postoperative day in all except patient 5; this patient had an acute myocardial infarct before surgery following severe congestive heart failure and an ACC time of 207 min.
Plasma BNP concentrations 24 h after surgery correlated significantly with left ventricular end-diastolic dimension and preoperative BNP levels. They did not correlate with any other haemodynamic or clinical data, including CPB time or ACC time ( Table  7 and Fig. 3 ).
Discussion
The BNP is rapidly synthesized and secreted by cardiac myocytes in response to acute stimulation, vasoactive agents and exercise. 11 12 the plasma concentration of BNP can be influenced acutely by certain stimuli. The normal plasma BNP concentration was reported by Lang et al. 13 to be 4.50 ± 0.69 pg/ml. In the present study the pre-operative (baseline) BNP level was 384.6 ± 963.5 pg/ml, which is extremely high and reflects the underlying cardiac disease of the patients studied. It remained unchanged in the immediate post-operative period and then became markedly elevated 24 h after surgery. The BNP levels on days 2, 4 and 7 after surgery were higher than the baseline level but the differences in concentration were not statistically significant. The increase in BNP level on the first postoperative day is likely to be due to acute heart failure after cardiac surgery and is consistent with previous reports. 14 In our opinion, the results of the present study suggest that the effects of cardiac surgery, which includes acute heart failure, on the BNP level may last for at least 1 week postoperatively. The values in this study had a large SD; this wide range of values may reflect the disease severity and pre-operative conditions of the participants. Further investigations on a larger number of patients, with correction of bias, are required.
In the present study, pre-operative plasma BNP concentration correlated significantly with age and left ventricular ejection fraction, indicating that the BNP level reflects cardiac function. This is consistent with previous reports 14 in which the BNP concentration was found to correlate significantly with pre-operative left ventricular ejection fraction.
Post-operatively, the plasma BNP concentration 24 h after surgery (peak value) correlated significantly with left ventricular end-diastolic dimension. This suggests that left ventricular distension due to acute heart failure after cardiac surgery induces the production of BNP; this finding is consistent with other published results. 15, 16 It is well known that the duration of ACC time during cardiac surgery is an index of myocardial injury; however, in the present study the CPB time and ACC time were not correlated with post-operative BNP level. This may be due to recent improvements in the techniques for myocardial protection. Six patients whose pre-operative BNP levels were > 500 pg/ml underwent cardiac surgery requiring a longer ACC time compared with the other patients in this study, and the BNP levels in these patients on the first post-operative day were also very high. The extremely high baseline BNP levels in this group may have affected this result.
The post-operative peak concentration of plasma BNP was also correlated with the preoperative plasma BNP concentration. This suggests that the severity of acute heart failure after cardiac surgery can be predicted by the pre-operative plasma BNP concentration. A high pre-operative plasma BNP concentration may, therefore, be a risk factor for cardiac surgery.
In conclusion, the results of this study showed that the plasma BNP concentration becomes markedly and acutely elevated after cardiac surgery, reflecting temporary ventricular dysfunction. Patients with preoperative left ventricular dysfunction and high BNP levels must be managed aggressively and monitored meticulously for heart failure after cardiac surgery.
